Author Archives: Bradley Bush, N.D.
The Centers for Disease Control and Prevention (CDC) recently released preliminary results of three ongoing studies indicating Lyme disease infection is ten times higher than previous studies showed. In a press release on Monday, August 19, 2013, the CDC stated … Continue reading
Last week’s post about serotonin and the immune connection got me thinking about the clinical utility of evaluating urinary serotonin levels. I have recently been fielding calls from practitioners questioning the value of urinary serotonin measures for patients with depression. … Continue reading
In the six years that I’ve been doing consults about NeuroScience‘s urinary neurotransmitter testing, I often hear healthcare practitioners state that their patient has a “nervous system imbalance”. Most believe that the “imbalance” is due to a disparity between excitatory … Continue reading
While NeuroScience, Inc. is nestled in a bucolic pocket of Wisconsin’s St. Croix River Valley, we avidly stay abreast of the latest health and science news. As we pointed out in a recent blog post, a new study by Gupta … Continue reading
We recently began offering IgE testing here at NeuroScience, Inc., and just about the same time an interesting, but disturbing study about allergies hit the newswire. It appears, based on a survey of nearly 38,000 children, that the prevalence of childhood … Continue reading